2023
DOI: 10.3389/fonc.2023.1120103
|View full text |Cite
|
Sign up to set email alerts
|

Identification and verification of the temozolomide resistance feature gene DACH1 in gliomas

Abstract: IntroductionThe most important chemotherapy treatment for glioma patients is temozolomide. However, the development of drug resistance severely restricts the use of temozolomide. Therefore, elucidating the mechanism of temozolomide resistance, enhancing temozolomide sensitivity, and extending patient survival are urgent tasks for researchers.MethodsTemozolomide resistance hub differential genes were identified using differential analysis and protein interaction analysis from the GEO datasets (GSE100736 and GSE… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 32 publications
0
2
0
Order By: Relevance
“…The DACH1 gene has been extensively studied and recognized as a crucial transcription regulator for the development of various organs and tissue, including the eyes, legs, nervous system, arterial vessels, and female reproductive tract in humans, mice, and Drosophila [ 52 , 53 , 54 , 55 , 75 , 76 , 77 ]. Furthermore, DACH1 has been recognized as a tumor suppressor gene in humans [ 56 , 57 , 58 , 59 , 60 , 61 , 62 ]. Despite its extensive study, limited research directly explored its role in hematopoiesis, with only two notable studies.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…The DACH1 gene has been extensively studied and recognized as a crucial transcription regulator for the development of various organs and tissue, including the eyes, legs, nervous system, arterial vessels, and female reproductive tract in humans, mice, and Drosophila [ 52 , 53 , 54 , 55 , 75 , 76 , 77 ]. Furthermore, DACH1 has been recognized as a tumor suppressor gene in humans [ 56 , 57 , 58 , 59 , 60 , 61 , 62 ]. Despite its extensive study, limited research directly explored its role in hematopoiesis, with only two notable studies.…”
Section: Discussionmentioning
confidence: 99%
“…Low expression of DACH1 has been observed in various types of tumors, such as breast tumors, esophageal cancer, lung cancer, and endometrial cancer. This low expression is correlated with increased tumor proliferation, metastasis, tumor mutation burden, reduced prognostic survival, radio sensitivity, and chemotherapy sensitivity [ 56 , 57 , 58 , 59 , 60 , 61 , 62 ]. Furthermore, high methylation of the DACH1 promoter results in reduced expression of DACH1 in tumors [ 62 , 63 ].…”
Section: Introductionmentioning
confidence: 99%